>
>
Oral Solid Dosage Contract Manufacturing Market – By Product (Tablet, Capsule, Powder), Type (Immediate, Delayed, & Controlled Release), Therapeutic area (Oncology, Cardiovascular, Infectious, Metabolic), Service, End-use, Global Forecast (2024 – 2032)
Download Free PDF

Oral Solid Dosage Contract Manufacturing Market
Get a free sample of this reportGet a free sample of this report Oral Solid Dosage Contract Manufacturing Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 10
Tables & Figures: 339
Countries covered: 22
Pages: 195
Download Free PDF
Oral Solid Dosage Contract Manufacturing Market Size
Oral Solid Dosage Contract Manufacturing Market size was valued at USD 35.6 billion in 2023 and is anticipated to grow at a CAGR of 5.6% between 2024 and 2032, driven by rising trend of outsourcing manufacturing by pharmaceutical companies. Outsourcing allows pharmaceutical companies to leverage the expertise and infrastructure of contract manufacturing organizations (CMOs) without the need for significant capital investment in manufacturing facilities and equipment.
Furthermore, advancements in pharmaceutical technology and formulation techniques are increasing the efficiency and quality of oral solid dosage manufacturing, driving more companies to opt for contract manufacturing services. Additionally, the increasing demand for pharmaceutical products, driven by the growing global population and the prevalence of chronic diseases, further fuels the market growth.
Oral solid dosage contract manufacturing refers to the outsourcing of the production of tablets, capsules, or other solid forms of medication to a third-party manufacturer. This type of contract manufacturing is common in the pharmaceutical industry, where companies may not have the capacity or expertise to manufacture certain medications in-house. Contract manufacturing allows pharmaceutical companies to focus on their core competencies, such as research and development, while leveraging the manufacturing capabilities of specialized contract manufacturers.
Oral Solid Dosage Contract Manufacturing Market Trends
Oral Solid Dosage Contract Manufacturing Market Analysis
Based on product, the market is segmented into tablets, capsules, powders, granules, and other products. The tablets segment dominated the market is 2023 and accounted for USD 11.6 billion.
Based on type, the oral solid dosage contract manufacturing market is segmented into immediate release, delayed release, and controlled release. The controlled release segment dominated the market with 52% of market share in 2023.
Based on therapeutic area, the oral solid dosage contract manufacturing market is categorized into oncology, cardiovascular diseases, metabolic disorders, neurological disorders, infectious diseases, gastrointestinal diseases, and other therapeutic areas. The oncology segment dominated the market and predicted to grow at CAGR of 5.4% over the forecast period.
Based on service, the oral solid dosage contract manufacturing market is segmented into drug product development, fill finish product manufacturing, active pharmaceutical ingredients (API) manufacturing, packaging and labelling, and other applications. The drug product development segment held highest market share in 2023 and is anticipated to reach USD 19.6 billion by 2032.
Based on end-use, the oral solid dosage contract manufacturing market is segmented into large size companies and medium & small size companies. The large size companies segment held highest market share in 2023 and is anticipated to grow at a CAGR of 5.2%.
North America oral solid dosage contract manufacturing market is anticipated to grow at a CAGR of 5.3% over the forecast years to reach USD 22.2 billion by 2032.
U.S. oral solid dosage contract manufacturing market was valued at USD 12.8 billion in 2023.
UK has emerged as a key player in the global market for oral solid dosage contract manufacturing, showcasing high growth potential.
China oral solid dosage contract manufacturing market is anticipated to witness lucrative growth between 2024 – 2032.
India oral solid dosage contract manufacturing market is expected to grow significantly over the years.
Oral Solid Dosage Contract Manufacturing Market Share
The oral solid dosage contract manufacturing industry is characterized by intense competition among key players striving to strengthen their foothold in the market. Key market players frequently undertake inorganic growth initiatives such as partnerships, mergers, and acquisitions to expand their market presence, enhance service portfolios, and gain a competitive advantage.
Oral Solid Dosage Contract Manufacturing Market Companies
Prominent players operating in the oral solid dosage contract manufacturing industry include:
Oral Solid Dosage Contract Manufacturing Industry News:
The oral solid dosage contract manufacturing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Type
Market, By Therapeutic Area
Market, By Service
Market, By End-use
The above information is provided for the following regions and countries: